CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to improve the accuracy and efficiency of preclinical drug discovery. Our PhysioMimix® suite of microphysiological systems, 3D-validated cells, consumable plates, and Contract Research Services facilitate the prediction of human responses to drug exposure, in the presence or absence of disease, so that new medicines can be brought to market more rapidly, cost-effectively and using fewer animals. Utilizing primary cells, our perfused single (Lung, Liver), and multi-organ (Intestine/Liver, Lung/Liver) models recapitulate the microarchitecture, microenvironment and function of their human counterparts in vitro. The approach provides a viable alternative to animal models where translatability to humans is predicted to be poor and for testing advanced drug modalities where human-specific targets and pathways are required. They generate physiologically relevant, human-translatable, mechanistic data that enables researchers to progress only the safest and most efficacious drugs into in vivo animal studies and be better prepared for clinical trials. Please follow us for regular updates. It starts here.
View Top Employees from CN BioWebsite | http://www.cn-bio.com |
Revenue | $49 million |
Funding | $18 million |
Employees | 47 (47 on RocketReach) |
Founded | 2008 |
Address | 332 Cambridge Science Park, Milton Road, Cambridge, England CB4 0WN, GB |
Phone | +44 1865 309600 |
Fax | +44 1865 854801 |
Industry | Biotechnology, Biotechnology Research, Business Services General, Biopharma, Pharmaceuticals, Business Services, Health Care, Science and Engineering, Life Science, Medical, Medical Device |
Web Rank | 17 Million |
Keywords | Cnbio, Cn Bio |
Competitors | Karus Therapeutics Limited, MIMETAS, REPROCELL Europe Ltd (formerly Reinnervate), Ultromics, Vaccitech |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies |
Looking for a particular CN Bio employee's phone or email?
The CN Bio annual revenue was $49 million in 2024.
Paul Brooks is the CEO of CN Bio.
47 people are employed at CN Bio.
CN Bio is based in Cambridge, England.
The NAICS codes for CN Bio are [54171, 541, 54, 5417, 541713].
The SIC codes for CN Bio are [873, 87].